{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:52:03Z","timestamp":1789851123523,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.biopha.2017.06.036","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:04:53Z","timestamp":1498277093000},"page":"370-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"special_numbering":"C","title":["Inducible nitric oxide synthase: Good or bad?"],"prefix":"10.1016","volume":"93","author":[{"given":"Maggie","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Caprnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kruzliak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Zulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.06.036_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2199 an inflammatory disease","volume":"340","author":"Russell","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2017.06.036_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","article-title":"Vascular oxidative stress, nitric oxide and atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.06.036_bib0015","first-page":"559","article-title":"Aspirin, ibuprofen, and other non steroidal anti-inflammatory drugs in cancer prevention: a ctitical review of non-selective COX-2 blockade","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2017.06.036_bib0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.295.3.306","article-title":"Aspirin for the primary prevention of cardiovascular events in women and men","volume":"295","author":"Berger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2017.06.036_bib0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.18773\/austprescr.2000.034","article-title":"COX-2 inhibitors","volume":"23","author":"Brooks","year":"2000","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.biopha.2017.06.036_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2169\/internalmedicine.55.4565","article-title":"Acute Myocardial infarction in a young man with hyperhomocysteinemia and pulmonary tuberculosis","volume":"55","author":"Ren","year":"2016","journal-title":"Intern. Med."},{"key":"10.1016\/j.biopha.2017.06.036_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0074-02762005000900016","article-title":"Mechanisms for suppressing NADPH oxidase in the vascular wall","volume":"100","author":"Dusting","year":"2005","journal-title":"Mem. Inst. Oswaldo. Cruz."},{"key":"10.1016\/j.biopha.2017.06.036_bib0045","doi-asserted-by":"crossref","first-page":"e113716","DOI":"10.1371\/journal.pone.0113716","article-title":"Resveratrol ameliorates high glucose and high-fat\/sucrose diet-induced vascular hyperpermeability involving Cav-1\/eNOS regulation","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.06.036_bib0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.redox.2013.12.023","article-title":"The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation","volume":"2","author":"Walsh","year":"2014","journal-title":"Redox. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1476-5381.2011.01249.x","article-title":"NOX1, 2, 4, 5: counting out oxidative stress","volume":"164","author":"Wingler","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0060","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","article-title":"Biochemistry, physiology and pathophysiology of NADPH oxidases in the cardiovascular system","volume":"110","author":"Lass\u00e8gue","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0065","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/01.CIR.0000012917.74432.66","article-title":"Superoxide production and expression of Nox family proteins in humans atherosclerosis","volume":"105","author":"Sorescu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2017.06.036_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","article-title":"Endothelial NADPH oxidases: which NOX to target in vascular disease?","volume":"25","author":"Drummond","year":"2014","journal-title":"Trends. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2017.06.036_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.chembiol.2011.12.017","article-title":"Rational design of small molecule inhibitors targeting the Rac GTPase \u2199 p67phox signaling axis inflammation","volume":"19","author":"Bosco","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/pr.110.002980","article-title":"NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair","volume":"63","author":"Jiang","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2017.06.036_bib0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","article-title":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets","volume":"10","author":"Drummond","year":"2011","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.biopha.2017.06.036_bib0090","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2337\/dc08-s247","article-title":"NADPH oxidases, reactive oxygen species, and hypertension","volume":"2","author":"Paravicini","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2017.06.036_bib0095","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1089\/ars.2010.3721","article-title":"Mechanisms of cardiovascular remodeling in hyperhomocysteinemia","volume":"15","author":"Steed","year":"2011","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.biopha.2017.06.036_bib0100","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/hq0901.096582","article-title":"Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-Deficient mice","volume":"21","author":"Zhou","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vph.2012.01.004","article-title":"Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of beta-catenin in response to homocysteine","volume":"56","author":"Beard","year":"2012","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1172\/JCI10588","article-title":"Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in murine model","volume":"107","author":"Hofmann","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2017.06.036_bib0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: cause or effect?","volume":"72","author":"Brattstr\u00f6m","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2017.06.036_bib0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.resp.2014.12.012","article-title":"Endothelial nitric oxide synthase uncoupling: a novel pathway in OSA induced vascular endothelial dysfunction","volume":"1","author":"Varadharaj","year":"2015","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4068\/cmj.2016.52.2.81","article-title":"Altered nitric oxide system in cardiovascular and renal diseases","volume":"52","author":"Lee","year":"2016","journal-title":"Chonnam. Med. J."},{"key":"10.1016\/j.biopha.2017.06.036_bib0130","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/514226","article-title":"Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis","volume":"177","author":"Leib","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2017.06.036_bib0135","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/clinchem\/44.8.1809","article-title":"Role of nitric oxide in cardiovascular disease: focus on the endothelium","volume":"44","author":"Cannon","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2017.06.036_bib0140","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.biopha.2017.06.036_bib0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/S0066-782X2000000400009","article-title":"Expression of nitric oxide synthases in the pathophysiology of cardiovascular diseases","volume":"74","author":"Viaro","year":"2000","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI0213265","article-title":"Cardiomyocyte overexpression of iNOS in mice results in peroxynutrite generation, heart block, and sudden death","volume":"109","author":"Mungrue","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2017.06.036_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2014.00073","article-title":"Exercise and NO production: relevance and implications in the cardiopulmonary system","volume":"2","author":"Nosarev","year":"2015","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0160","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1089\/ars.2014.6158","article-title":"Central role of eNOS in the maintenance of endothelial homeostasis","volume":"22","author":"Heiss","year":"2015","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.biopha.2017.06.036_bib0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","article-title":"Vascular oxidative stress, nitric oxide and atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.06.036_bib0170","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/ars.2008.2403","article-title":"Nitric oxide, NAD(P)H oxidase, and atherosclerosis","volume":"11","author":"Muller","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.biopha.2017.06.036_bib0175","first-page":"119","article-title":"Nitric oxide, inducible nitric oxide synthase and inflammation in veterinary medicine, Anim","volume":"3","author":"Hunter","year":"2002","journal-title":"Health. Res. Rev."},{"key":"10.1016\/j.biopha.2017.06.036_bib0180","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/01.CIR.101.23.2742","article-title":"Attenuation of myocardial ischemia\/reperfusion injury by superinduction of inducible nitric oxide synthase","volume":"101","author":"Kanno","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2017.06.036_bib0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0008-6363(01)00472-2","article-title":"Nitric oxide as a mediator of delayed pharmacological (A1 receptor triggered) preconditioning; is eNOS masquerading as iNOS?","volume":"53","author":"Bell","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2013.06.002","article-title":"Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: Implications for gene therapy of restenosis","volume":"230","author":"Forbes","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.06.036_bib0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0008-6363(99)00316-8","article-title":"Inducible nitric oxide synthase and cardiovascular disease","volume":"45","author":"Shah","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0200","doi-asserted-by":"crossref","first-page":"e107734","DOI":"10.1371\/journal.pone.0107734","article-title":"Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia","volume":"9","author":"Dayal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.06.036_bib0205","first-page":"469","article-title":"Nitric oxide and superoxide in inflammation and immune regulation","volume":"54","author":"Guzik","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.lfs.2006.01.043","article-title":"Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice","volume":"79","author":"Miyoshi","year":"2006","journal-title":"Life. Sci."},{"key":"10.1016\/j.biopha.2017.06.036_bib0215","first-page":"4872","article-title":"Nitric oxide mediated effects of nebivolol in myocardial infarction: the source of nitric oxide","volume":"19","author":"Mercanoglu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2017.06.036_bib0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.atherosclerosis.2014.04.020","article-title":"Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration","volume":"235","author":"Huang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.06.036_bib0225","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jphp.12204","article-title":"Agmatine ameliorates atherosclerosis progression and endothelial dysfunction in high cholesterol-fed rabbits","volume":"66","author":"El-Awady","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0230","first-page":"117","article-title":"Excess nitric oxide impairs LXR(\u03b1)-ABCA1-dependent cholesterol efflux in macrophage foam cells","volume":"229","author":"Zhao","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0235","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.acthis.2012.02.004","article-title":"The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans","volume":"114","author":"Gochman","year":"2012","journal-title":"Acta. Histochem."},{"key":"10.1016\/j.biopha.2017.06.036_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep17939","article-title":"Gene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.06.036_bib0245","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.4049\/jimmunol.179.12.8090","article-title":"Selective inhibition of inducible NO synthase activity in vivo reverses inflammatory abnormalities in Surfactant Protein D-Deficient mice","volume":"179","author":"Atochina-Vasserman","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0250","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.RES.0000264081.78659.45","article-title":"iNOS deficiency protects the heart from systolic overload induced ventricular hypertrophy and congestive heart failure","volume":"100","author":"Zhang","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/cvr\/28.1.34","article-title":"Effects of a nitric oxide synthase inhibitor in humans with septic shock","volume":"28","author":"Petros","year":"1994","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0260","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1096\/fj.02-0668fje","article-title":"Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice","volume":"17","author":"Chauhan","year":"2003","journal-title":"FASEB. J."},{"key":"10.1016\/j.biopha.2017.06.036_bib0265","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjp.0707211","article-title":"Interactions between NO, CO and an endothelium-derived hyperpolarizing factor (EDHF) in maintaining patency of the ductus arteriosus in the mouse","volume":"151","author":"Baragatti","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0270","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1681\/ASN.2006050541","article-title":"Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic\/endothelial nitric oxide synthase knockout mice","volume":"18","author":"Quaschning","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0275","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1172\/JCI119736","article-title":"Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis","volume":"100","author":"Shears","year":"1997","journal-title":"J. Clin Invest."},{"key":"10.1016\/j.biopha.2017.06.036_bib0280","first-page":"439","article-title":"Proliferation of macrophages due to the inhibition of inducible nitric oxide synthasis by oxidized low-density lipoproteins","volume":"14","author":"Brunner","year":"2015","journal-title":"EXCLI. J."},{"key":"10.1016\/j.biopha.2017.06.036_bib0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jlb.54.2.171","article-title":"Inflammation, immunoregulation, and inducible nitric oxide synthase","volume":"54","author":"Nussler","year":"1993","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0290","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0008-6363(98)00249-1","article-title":"Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS","volume":"41","author":"Bhagat","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0295","first-page":"505","article-title":"Lack of cell stress markers in fibrous cap cells in the left main coronary Artery","volume":"28","author":"Rai","year":"2013","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0300","doi-asserted-by":"crossref","first-page":"38642","DOI":"10.1038\/srep38642","article-title":"Pleiotropic effects of acarbose on atherosclerosis development in rabbits are mediated via upregulating AMPK signals","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2017.06.036_bib0305","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0039-6060(99)70189-3","article-title":"Inducible nitric oxide synthase (iNOS) gene deficiency increases themortality of sepsis in mice","volume":"126","author":"Cobb","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.biopha.2017.06.036_bib0310","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1523-1755.2001.0590041290.x","article-title":"Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction","volume":"59","author":"Miyajima","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2017.06.036_bib0315","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/gast.1997.v112.pm9041266","article-title":"Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation","volume":"112","author":"McCafferty","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2017.06.036_bib0320","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1073\/pnas.96.20.11507","article-title":"The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene","volume":"96","author":"Guo","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.06.036_bib0325","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0008-6363(02)00414-5","article-title":"Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia\/reperfusion injury and mediates the late phase of preconditioning","volume":"55","author":"Bolli","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.biopha.2017.06.036_bib0335","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/01.ATV.0000219672.68024.bc","article-title":"COX-2 in cardiovascular disease","volume":"26","author":"Bishop-Bailey","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.ATV.19.3.646","article-title":"Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages","volume":"19","author":"Baker","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1073\/pnas.1517642113","article-title":"Systemic study of constitutive cyclooxygenase-2 expression: role of NF-kB and NFAT transcriptional pathways","volume":"113","author":"Kirkby","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.biopha.2017.06.036_bib0350","first-page":"113","article-title":"Inhibitors of cyclooxygenases: mechanisms, selectivity and uses","volume":"57","author":"Botting","year":"2006","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.06.036_bib0355","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2016.04.004","article-title":"The coxib case: are EP receptors really guilty?","volume":"249","author":"Santilli","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2017.06.036_bib0360","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF03401781","article-title":"Inducible nitric oxide synthase and inflammatory diseases","volume":"6","author":"Zamora","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.biopha.2017.06.036_bib0365","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1152\/ajpheart.00690.2008","article-title":"Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice","volume":"295","author":"Ye","year":"2008","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217313562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217313562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:12:49Z","timestamp":1766023969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217313562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":73,"alternative-id":["S0753332217313562"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.036","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inducible nitric oxide synthase: Good or bad?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}